Intravenous single dose of tranexamic acid safely reduces blood loss and the need for transfusion in elderly patients with hip fracture. A randomized double-blinded controlled trial at 1-year follow-up
<p>Background: A hip fracture usually presents significant blood loss in the perioperative period, with a transfusion rate of 20-60%. In order to reduce the complications associated with this procedure, the administration of Tranexamic Acid (TXA) has been implemented in the treatment of periop...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | ספר |
| יצא לאור: |
Annals of Musculoskeletal Medicine - Peertechz Publications,
2023-11-21.
|
| נושאים: | |
| גישה מקוונת: | Connect to this object online. |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|